Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Radiolabelled T4 refers to the thyroid hormone thyroxine (T4) that has been chemically tagged with a radioactive isotope, typically iodine-125 or iodine-131. This compound is primarily used as a diagnostic tool in nuclear medicine and laboratory research to study thyroid function, hormone kinetics, and protein binding. In clinical settings, radiolabelled T4 is used in radioimmunoassays for measuring serum levels of free or total T4 and for investigating disorders of thyroid hormone transport or metabolism. The mechanism involves the same biological activity as endogenous thyroxine—regulation of metabolism via activation of nuclear thyroid hormone receptors—but the radioactive label allows tracking and quantification through imaging or detection equipment. Radiolabelled T4 is not used therapeutically but rather as a tracer in diagnostic procedures and research applications[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on radiolabelled thyroxine.